Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia

Asir John Samuel68 enrolled

Overview

Hyperbilirubinemia is the most common problem seen in neonates, owing to severe complications in their lifetime. The study design of the study is pretest - a posttest experimental design. Criterion-based purposive sampling will be used for recruiting the neonates. In the study neonates will be selected according to the selection criteria and will be allocated into two groups using computer-based randomization.The Intervention group - neonates will receive tactile and kinesthetic stimulation for 15 minutes for 3 consecutive days, 1 hour after feeding twice daily along with Phototherapy, Control group - Phototherapy alone will be given along with conventional NICU care. Total serum bilirubin will be assessed as outcome measures daily once. Transcutaneous bilirubin will be assessed after every intervention.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Neonatal Hyperbilirubinemia

Interventions

Massage therapy includes stroking, kneading, rolling, tapping, vibration and effleurage over the face, chest ,abdomen and back. Massage therapy will be given for 5 minutes and will be repeated twice.

Kinaesthetic stimulationOTHER

Kinaesthetic stimulation includes passive flexion and extension movements of shoulder joint, elbow joint, hip joint, knee joint and both lower limbs together. It will be given for 5 minutes in each intervention

Eligibility

Sex: ALLMin age: 24 HoursMax age: 10 DaysHealthy volunteers:

Medical Language ↔ Plain English

1. New born in Neonatal Intensive Care Unit 2. Stable vitals 3. Full Term and Preterm neonates 4. Gestational age 34 weeks to 40 weeks 5. Birth weight -1800 - 3000 g 6. APGAR Score at birth of 8 -10 7. Total serum bilirubin levels \> 10 mg/dL

Locations (1)

Civil Hospital

Ropar, Punjab, India

Outcomes

Primary Outcomes

Total Serum Bilirubin (TSB)

It will measure total bilirubin level in blood of neonates

Time frame: Changes in the Total Serum Bilirubin level will be measured at baseline and at the end of three days intervention

Transcutaneous Bilirubin (TcB)

Transcutaneous Bilirubin will measure neonatal jaundice.

Time frame: Changes in the Transcutaneous Bilirubin level will be measured daily for three days before and after intervention

Weight Gain

Weight gain will evaluate the change in neonatal weight

Time frame: Changes in the weight will be measured at baseline and at the end of three days intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.